About X-Pressure
X-Pressure is a company based in Toulouse (France) founded in 2021 by Eric Schmidt and Pierre-Edouard De Lamy. X-Pressure has raised $4.94 million across 1 funding round from investors including Bpifrance, IRDI Capital Investissement and M Capital. X-Pressure offers products and services including XP One. X-Pressure operates in a competitive market with competitors including NeuroKaire, Manus Neuro, Luciole Medical, Rhaeos and RetiSpec, among others.
- Headquarter Toulouse, France
- Founders Eric Schmidt, Pierre-Edouard De Lamy
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.94 M (USD)
in 1 rounds
-
Latest Funding Round
$4.94 M (USD), Series A
Jul 10, 2023
-
Investors
Bpifrance
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of X-Pressure
X-Pressure offers a comprehensive portfolio of products and services, including XP One.
Enables NPH detection via CSF infusion tests and algorithms.
People of X-Pressure
Unlock access to complete
Unlock access to complete
Funding Insights of X-Pressure
X-Pressure has successfully raised a total of $4.94M through 1 strategic funding round. The most recent funding activity was a Series A round of $4.94 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in X-Pressure
X-Pressure has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Bpifrance, IRDI Capital Investissement and M Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment services are provided to startups, SMEs, and ETI in South-West France.
|
Locked | Locked | Locked | |
|
Investment solutions are provided by M Capital for various sectors.
|
Locked | Locked | Locked | |
|
Corporate consultancy, advisory, and funding services are provided to businesses.
|
Locked | Locked | Locked |
Investor details for X-Pressure
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by X-Pressure
Investment portfolio details for X-Pressure
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - X-Pressure
Detailed financials for X-Pressure
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
X-Pressure Comparisons
Peer comparison for X-Pressure
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of X-Pressure
X-Pressure operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NeuroKaire, Manus Neuro, Luciole Medical, Rhaeos and RetiSpec, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Platform offering personalized treatment for psychiatric and neurological conditions
|
|
| Locked | Locked | Locked |
Devices for neuromotor impairment biomarkers are provided.
|
|
| Locked | Locked | Locked |
Brain monitoring devices and analytics platforms are developed and provided.
|
|
| Locked | Locked | Locked |
Noninvasive device developed for CSF monitoring and hydrocephalus management.
|
|
| Locked | Locked | Locked |
Non-invasive eye scanner for early Alzheimer’s detection is developed.
|
|
| Locked | Locked | Locked |
Brain activity data is analyzed digitally for medical providers.
|
Detailed competitors of X-Pressure
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on X-Pressure
Complete news archive for X-Pressure
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about X-Pressure
X-Pressure was founded in 2021 and raised its 1st funding round 2 years after it was founded.
X-Pressure is headquartered in Toulouse, France. It is registered at Toulouse, Occitanie, France.
Pierre-Edouard De Lamy is the current CEO of X-Pressure. They have also founded this company.
X-Pressure is a funded company, having raised a total of $4.94M across 1 funding round to date.
X-Pressure was founded in 2021 in Toulouse, France, within the medical device sector. A sensor is attached to the end of a lumbar puncture needle by the company to assess opening pressure. Measurements are processed through a mobile application and AI-based algorithms. This approach supports the diagnosis of brain diseases in clinical settings. Operations focus on healthcare technology development and deployment.
X-Pressure's top competitors include NeuroKaire, Brain.Space and RetiSpec.
X-Pressure offers XP One.
X-Pressure has 3 investors. Key investors include Bpifrance, IRDI Capital Investissement, and M Capital.